Viatris to Participate in Upcoming Investor Conferences
Viatris (Nasdaq: VTRS) will participate in two investor events in November 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Viatris (Nasdaq: VTRS) will participate in two investor events in November 2025. The company will appear in a fireside chat at the UBS Global Healthcare Conference on November 11, 2025 at 8:45 a.m. ET, and in a fireside chat at the Jefferies Global Healthcare Conference in London on November 18, 2025 at 11:30 a.m. GMT / 6:30 a.m. ET. Investors and the public can listen live and access archived sessions at investor.viatris.com for a limited time after each event.
Details
News Market Reaction – VTRS
On Oct 13, the day this news came out, VTRS closed 1.23% above the previous close.
Data tracked by StockTitan Argus for the Oct 13 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Company will participate in a fireside chat at the UBS Global Healthcare Conference 2025 on November 11, 2025, at 8:45 a.m. ET.
In addition, the Company will take part in a fireside chat at the Jefferies Global Healthcare Conference in
Investors and the general public are invited to listen to both sessions at their respective times at investor.viatris.com. An archived version of each session will be available following the live event and can be accessed at the same location for a limited time.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-participate-in-upcoming-investor-conferences-302581460.html
SOURCE Viatris Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.